AI Stock Analysis - Ginkgo Bioworks Holdings (DNA)
Analysis generated March 10, 2026.
Ginkgo Bioworks Holdings is a leading company in the field of synthetic biology, leveraging advanced bioengineering to develop novel solutions for various industries. Known for its innovative approach, Ginkgo collaborates with companies to solve complex biological problems, spanning pharmaceuticals, environment, food, and agriculture. The company's mission revolves around deploying organisms designed via genetic engineering to produce critical products in diverse markets.
Stock Alerts - Ginkgo Bioworks Holdings (DNA)
 |
Ginkgo Bioworks Holdings | March 6 Price is down by -6.3% in the last 24h. |
|
Ginkgo Bioworks Holdings | March 5 Price is up by 6.1% in the last 24h. |
|
Ginkgo Bioworks Holdings | March 3 Price is down by -6.5% in the last 24h. |
|
Ginkgo Bioworks Holdings | February 27 Price is down by -18.6% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Ginkgo Bioworks Holdings
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 5 | Sign up | Sign up | Sign up |
| Sentiment | 48 | Sign up | Sign up | Sign up |
| Webpage traffic | 6,000 | Sign up | Sign up | Sign up |
| Employee Rating | 60 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1 | Sign up | Sign up | Sign up |
| Facebook Followers | 4,611 | Sign up | Sign up | Sign up |
| Instagram Followers | 12,454 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 19 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 12,670 | Sign up | Sign up | Sign up |
| X Followers | 39,016 | Sign up | Sign up | Sign up |
| X Mentions | 62 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 6 | Sign up | Sign up | Sign up |
| Linkedin Employees | 653 | Sign up | Sign up | Sign up |
About Ginkgo Bioworks Holdings
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming.
| Price | $6.34 |
| Target Price | Sign up |
| Volume | 819,469 |
| Market Cap | $403M |
| Year Range | $6.34 - $16.14 |
| Dividend Yield | 0% |
| Analyst Rating | 33% buy |
| Industry | Biotechnology |
In the news
 |
Ginkgo Bioworks Holdings, Inc. (DNA) Q4 2025 Earnings Call TranscriptFebruary 27 - Seeking Alpha |
 |
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Drops Despite Market Gains: Important Facts to NoteJanuary 23 - Yahoo |
Ginkgo Bioworks Holdings, Inc. (DNA) Presents at 44th Annual J.P. Morgan Healthcare Conference - SlideshowJanuary 23 - SeekingAlpha |
|
 |
Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It HappenMarch 7 - Benzinga |
Ginkgo Bioworks Rolls Out Ginkgo Cloud LabMarch 1 - Benzinga |
|
 |
Ginkgo Bioworks Makes Major PivotMarch 1 - SeekingAlpha |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 39M | 13M | 26M | -81M | -67M | -1.450 |
| Q2 '25 | 50M | 15M | 35M | -60M | -46M | -1.100 |
| Q1 '25 | 48M | 12M | 36M | -91M | -68M | -1.680 |
| Q4 '24 | 44M | 9.6M | 34M | -108M | -143M | -2.000 |
| Q3 '24 | 89M | 10M | 79M | -56M | -35M | -1.080 |
Insider Transactions View All
| Coen Steven P. filed to sell 8,321 shares at $8.9. January 22 '26 |
| Coen Steven P. filed to sell 7,488 shares at $8.9. December 16 '25 |
| Coen Steven P. filed to sell 6,738 shares at $13.6. October 21 '25 |
| Coen Steven P. filed to sell 5,503 shares at $15. October 3 '25 |
| HENRY CHRISTIAN O filed to sell 24,310 shares at $11.1. September 10 '25 |
Similar companies
Read more about Ginkgo Bioworks Holdings (DNA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Ginkgo Bioworks Holdings
The Market Cap of Ginkgo Bioworks Holdings is $403M.
Currently, the price of one share of Ginkgo Bioworks Holdings stock is $6.34.
The DNA stock price chart above provides a comprehensive visual representation of Ginkgo Bioworks Holdings' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Ginkgo Bioworks Holdings shares. Our platform offers an up-to-date DNA stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Ginkgo Bioworks Holdings (DNA) does not offer dividends to its shareholders. Investors interested in Ginkgo Bioworks Holdings should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Ginkgo Bioworks Holdings are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
